Roxithromycin Tablets 150mg (Rulid® / ルリッド錠150)

JPY ¥2,900

Japanese acid-stable, long-acting macrolide antibiotic (Roxithromycin 150mg). Oral tablet for skin, respiratory tract, ear, nose, sinus, and dental infections. 100 tablets [10 tablets (PTP) x 10]. Mfd. by Sanofi K.K., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥2,668
10 - 19 12% JPY ¥2,552
20 + 18% JPY ¥2,378
SKU: RUL-150-TAB Category:

Description

Product Overview / 商品概要

Rulid Tablets 150mg (ルリッド錠150)
Generic: Roxithromycin / ロキシスロマイシン
Therapeutic Category: Acid-stable, long-acting macrolide antibiotic / 酸安定性・持続型マクロライド系抗生剤
Manufactured by: Sanofi K.K. / サノフィ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Roxithromycin (JP) 150mg (potency) per tablet / 1錠中 日局ロキシスロマイシン 150mg(力価)
Additives: Corn starch, Low-substituted hydroxypropylcellulose, Povidone, Talc, Magnesium stearate, Light anhydrous silicic acid, Polyoxyethylene [160] polyoxypropylene [30] glycol, Hypromellose, Glucose, Propylene glycol, Titanium oxide / トウモロコシデンプン、低置換度ヒドロキシプロピルセルロース、ポビドン、タルク、ステアリン酸マグネシウム、軽質無水ケイ酸、ポリオキシエチレン[160]ポリオキシプロピレン[30]グリコール、ヒプロメロース、ブドウ糖、プロピレングリコール、酸化チタン
Appearance: White film-coated tablet; diameter 9.1mm, thickness 4.0mm, weight 215mg, identification code: RU 164 D
外観: 白色のフィルムコーティング錠、直径9.1mm、厚さ4.0mm、重量215mg、識別コード RU 164 D

Indications / 効能効果

EN: Susceptible organisms: Staphylococcus spp., Streptococcus spp., Streptococcus pneumoniae, Moraxella (Branhamella) catarrhalis, Propionibacterium acnes, Mycoplasma pneumoniae.
Indications: Superficial skin infections, deep skin infections, lymphangitis/lymphadenitis, chronic pyoderma, acne vulgaris (with purulent inflammation), pharyngitis/laryngitis, tonsillitis, acute bronchitis, pneumonia, otitis media, sinusitis, periodontitis, pericoronitis, jaw osteitis
JA: ○適応菌種:本剤に感性のブドウ球菌属、レンサ球菌属、肺炎球菌、モラクセラ(ブランハメラ)・カタラーリス、アクネ菌、肺炎マイコプラズマ(マイコプラズマ・ニューモニエ)
○適応症:表在性皮膚感染症、深在性皮膚感染症、リンパ管・リンパ節炎、慢性膿皮症、ざ瘡(化膿性炎症を伴うもの)、咽頭・喉頭炎、扁桃炎、急性気管支炎、肺炎、中耳炎、副鼻腔炎、歯周組織炎、歯冠周囲炎、顎炎

Dosage and Administration / 用法用量

EN: The usual adult dose is 300mg (potency) of roxithromycin per day, administered orally in 2 divided doses.
JA: 通常、成人にはロキシスロマイシンとして1日量300mg(力価)を2回に分割し、経口投与する。

Contraindications / 禁忌

EN: 2.1 Patients with a history of hypersensitivity to this product.
2.2 Patients receiving ergotamine tartrate/anhydrous caffeine/isopropylantipyrine (Clairmin) or dihydroergotamine mesylate.
JA: 2.1 本剤に対し過敏症の既往歴のある患者
2.2 エルゴタミン酒石酸塩・無水カフェイン・イソプロピルアンチピリン、ジヒドロエルゴタミンメシル酸塩を投与中の患者

Regulatory Information / 規制情報

Approval No.: 20300AMZ00036
Sales Started: March 1991 / 1991年3月
Classification Code: 876149
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10]
500 tablets [10 tablets (PTP) x 50]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Roxithromycin Tablets 150mg (Rulid® / ルリッド錠150)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Roxithromycin Tablets 150mg (Rulid®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.